SOURCE: BioPharmetics, Inc.

August 02, 2006 11:54 ET

BioPharmetics, Inc. Secures Order From Canada's Largest Retail Chain

NORTH HOLLYWOOD, CA -- (MARKET WIRE) -- August 2, 2006 --BioPharmetics, Inc. (PINKSHEETS: BPMT) announced the company has secured an order for their Toma® Nail polish to be placed in The Bay Company's upscale Zeller's Department stores throughout greater Canada.

"Through the dedicated work of our distribution partner, Cosmetics Based on Nature, the Toma® Nail Polish will now be available to the retail public in major department stores throughout Canada," stated Mr. Paul D. Lisenby, CEO of BioPharmetics, Inc. Mr. Lisenby adds, "We continue to manufacture quality products and this is verified by the Bay Company selecting our product to be placed in their stores. We're extremely excited about the growth of the company and have many other retailers interested in placing our products in their locations. The interest is really starting to take hold and we expect sales to increase dramatically over the next 6 months."

For more information about all of BioPharmetics, Inc. products, please visit the website at www.biopharmetics.com

About BioPharmetics, Inc. (PINKSHEETS: BPMT)

BioPharmetics, Inc. is a manufacturer and distributor of quality pharmaceutical, cosmetic, and anti-aging products. The company has three divisions: biotechnology, pharmaceuticals, and cosmetics/cosmeceuticals, working in unison to develop, manufacture, and distribute, high-quality products in the retail, wholesale, and professional markets. Brands currently offered include Toma™, Isseo™, Molo Africa™, Micha™, and Natural Angel™. BioPharmetics, Inc. also private labels many brands of cosmetics and cosmeceuticals for salons and retail stores as well as compounding specialized prescriptions for doctors nationwide.

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

Contact Information

  • Contact:
    FutureTechIR for BioPharmetics
    Investor Relations
    (817) 812-2105
    or
    (727) 417-9338